UPDATED Apr 22, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$731.33 | 0.7% | 90.0% | US$658.8b | US$813.32 | PE125.7x | E27.2% | 0.7% | ||
MRK | US$126.94 | 0.9% | 8.9% | US$321.5b | US$137.58 | PE880.9x | E25.9% | 2.4% | ||
JNJ | US$149.12 | 0.8% | -9.7% | US$359.3b | US$173.60 | PE18.7x | E5.1% | 3.3% | ||
ABBV | US$167.89 | 0.9% | 1.8% | US$297.3b | US$184.14 | PE61.7x | E23.4% | 3.7% | ||
AMGN | US$271.91 | 1.1% | 11.0% | US$145.8b | US$300.27 | PE21.7x | E8.8% | 3.3% | ||
PFE | US$26.26 | 1.0% | -33.2% | US$148.7b | US$31.62 | PE69.7x | E22.1% | 6.4% | ||
VRTX | US$399.92 | 1.4% | 20.5% | US$103.4b | US$460.34 | PE28.6x | E11.5% | n/a | ||
TMO | US$548.38 | 0.7% | 0% | US$209.3b | US$610.29 | PE34.9x | E10.6% | 0.3% | ||
MRNA | US$104.46 | 3.0% | -22.6% | US$40.0b | US$134.30 | PS5.8x | E56.0% | n/a | ||
GRPH | US$22.26 | 580.7% | 861.6% | US$190.4m | n/a | PB7.1x | E36.4% | n/a | ||
ICLR | US$297.93 | 3.4% | 46.6% | US$24.6b | US$352.79 | PE40.1x | E15.7% | n/a | ||
IQV | US$231.34 | 1.4% | 20.7% | US$42.1b | US$275.38 | PE31x | E12.7% | 0% | ||
ILMN | US$120.25 | 2.4% | -45.0% | US$19.2b | US$158.58 | PS4.3x | E68.4% | n/a | ||
BMY | US$49.14 | 0.4% | -30.0% | US$99.6b | US$56.20 | PE12.4x | E7.8% | 4.9% | ||
DHR | US$236.08 | 0.2% | 1.8% | US$174.8b | US$264.88 | PE41.6x | E11.3% | 0.4% | ||
NTRA | US$88.61 | 3.9% | 74.8% | US$10.7b | US$102.65 | PS9.9x | E68.7% | n/a | ||
REGN | US$900.16 | 0.4% | 14.0% | US$96.7b | US$1,035.68 | PE24.5x | E10.9% | n/a | ||
A | US$133.91 | 0.9% | 2.7% | US$39.2b | US$150.51 | PE31.8x | E9.1% | 0.7% | ||
CRL | US$232.56 | 2.5% | 24.0% | US$11.9b | US$270.67 | PE25.2x | E11.4% | n/a | ||
BNTX | US$88.01 | 1.4% | -23.0% | US$21.2b | US$113.46 | PE21.4x | E-20.2% | n/a | ||
QGEN | US$41.22 | 3.1% | -9.4% | US$9.1b | US$50.74 | PE26.7x | E11.3% | n/a | ||
EXAS | US$62.41 | 2.4% | -1.8% | US$11.3b | US$89.27 | PS4.5x | E61.9% | n/a | ||
RVMD | US$36.43 | 4.3% | 58.0% | US$6.0b | US$41.58 | PS518.1x | E9.6% | n/a | ||
WST | US$375.35 | 0.9% | 5.1% | US$27.5b | US$392.80 | PE46.3x | E8.3% | 0.2% |